201 related articles for article (PubMed ID: 24169613)
1. Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials.
Wang AY; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ
Nephrol Dial Transplant; 2013 Nov; 28(11):2875-88. PubMed ID: 24169613
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.
Wang Y; Ivany JN; Perkovic V; Gallagher MP; Woodward M; Jardine MJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009631. PubMed ID: 27039404
[TBL] [Abstract][Full Text] [Related]
3. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
[TBL] [Abstract][Full Text] [Related]
4. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
5. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis.
Sheng KX; Zhang P; Li JW; Cheng J; He YC; Böhlke M; Chen JH
Clin Microbiol Infect; 2020 May; 26(5):545-552. PubMed ID: 31857208
[TBL] [Abstract][Full Text] [Related]
7. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah P; Shah V
Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
[TBL] [Abstract][Full Text] [Related]
8. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
Labriola L; Crott R; Jadoul M
Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
[TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters.
McCann M; Moore ZE
Cochrane Database Syst Rev; 2010 Jan; (1):CD006894. PubMed ID: 20091610
[TBL] [Abstract][Full Text] [Related]
10. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Li Z; Zhang L; Yang J; Yang Y; Tang Y; Fu P
Am J Kidney Dis; 2014 Mar; 63(3):479-90. PubMed ID: 24125729
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.
Jaffer Y; Selby NM; Taal MW; Fluck RJ; McIntyre CW
Am J Kidney Dis; 2008 Feb; 51(2):233-41. PubMed ID: 18215701
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters.
Mokrzycki MH; Jean-Jerome K; Rush H; Zdunek MP; Rosenberg SO
Kidney Int; 2001 May; 59(5):1935-42. PubMed ID: 11318966
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
14. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
Shah PS; Shah VS
Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.
Liu J; Wang C; Zhao H; Zhang J; Ma J; Hou Y; Zou H
Int J Clin Exp Med; 2015; 8(8):11985-95. PubMed ID: 26550111
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
17. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
Weijmer MC; van den Dorpel MA; Van de Ven PJ; ter Wee PM; van Geelen JA; Groeneveld JO; van Jaarsveld BC; Koopmans MG; le Poole CY; Schrander-Van der Meer AM; Siegert CE; Stas KJ;
J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
19. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
